CIK 0001285819
- Non-accelerated filer
- Smaller reporting company
OMEROS CORP
Sign in to watch- Ticker
- OMER
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- Operating
- EIN
- 911663741
- Phone
- +1 206-676-5000
- Business address
- 201 ELLIOTT AVENUE WEST, SEATTLE, WA, 98119
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,837,566
- in 4 filings, $626K under 10b5-1 plans
Net −$1,837,566. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 78 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-05-15 | JACOBSEN MICHAEL A VP Finance and CAO | Sale | −12,812 | $24.95 | $320K | 8,500 |
| 2018-05-15 | JACOBSEN MICHAEL A VP Finance and CAO | Exercise or conversion | +5,000 | $9.37 | $47K | 13,500 |
| 2018-05-15 | JACOBSEN MICHAEL A VP Finance and CAO | Exercise or conversion · Stock Option (Right to Buy) | −12,812 | 34,188 | ||
| 2018-05-15 | JACOBSEN MICHAEL A VP Finance and CAO | Exercise or conversion · Stock Option (Right to Buy) | −5,000 | 29,188 | ||
| 2018-05-14 | JACOBSEN MICHAEL A VP Finance and CAO | Exercise or conversion | +10,980 | $9.37 | $103K | 19,480 |
| 2018-05-14 | JACOBSEN MICHAEL A VP Finance and CAO | Sale | −10,980 | $22.45 | $247K | 8,500 |
| 2018-05-14 | JACOBSEN MICHAEL A VP Finance and CAO | Exercise or conversion · Stock Option (Right to Buy) | −10,980 | 47,000 | ||
| 2018-04-08 | Demopulos Gregory A MD Chairman, CEO & President | Grant or award · Stock Option (Right to Buy) | +350,000 | 350,000 | ||
| 2018-04-08 | JACOBSEN MICHAEL A VP Finance and CAO | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2018-04-08 | Kelbon Marcia S. VP Patent and General Counsel | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2018-01-04 | JACOBSEN MICHAEL A VP Finance and CAO | Exercise or conversion | +1,000 | $9.37 | $9K | 8,500 |
| 2018-01-04 | JACOBSEN MICHAEL A VP Finance and CAO | Exercise or conversion · Stock Option (Right to Buy) | −1,000 | 57,980 | ||
| 2018-01-03 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion | +62,528 | $9.37 | $586K | 239,169 |
| 2018-01-03 | Kelbon Marcia S. VP Patent and General Counsel | Sale | −62,528 | $21.45 | $1.3M | 176,641 |
| 2018-01-03 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion | +3,000 | $6.05 | $18K | 179,641 |
| 2018-01-03 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion | +5,004 | $6.05 | $30K | 184,645 |
| 2018-01-03 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion · Stock Option (Right to Buy) | −62,528 | 40,972 | ||
| 2018-01-03 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion · Stock Option (Right to Buy) | −3,000 | 0 | ||
| 2018-01-03 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion · Stock Option (Right to Buy) | −5,004 | 69,996 | ||
| 2018-01-03 | JACOBSEN MICHAEL A VP Finance and CAO | Exercise or conversion | +1,020 | $9.37 | $10K | 8,520 |
Page 13 of 20 · 391 trades